scholarly journals The spectrum of non alcoholic fatty liver disease in morbidly obese patients: prevalence and associate risk factors

2013 ◽  
Vol 28 (11) ◽  
pp. 788-793 ◽  
Author(s):  
Suerda Guiomar Feijó ◽  
José Milton de Castro Lima ◽  
Maria Aparecida Alves de Oliveira ◽  
Régia Maria Vidal Patrocínio ◽  
Luis Gonzaga Moura-Junior ◽  
...  
Keyword(s):  
Risk Factors ◽  
Liver Disease ◽  
Fatty Liver ◽  
Fatty Liver Disease ◽  
Morbidly Obese ◽  
Obese Patients ◽  
Alcoholic Fatty Liver ◽  
Associate Risk ◽  
Alcoholic Fatty Liver Disease

scholarly journals CORRELATION OF NON-ALCOHOLIC FATTY LIVER DISEASE AND FEATURES OF METABOLIC SYNDROME IN MORBIDLY OBESE PATIENTS IN THE PREOPERATIVE ASSESSMENT FOR BARIATRIC SURGERY

2016 ◽  
Vol 29 (4) ◽  
pp. 260-263 ◽  
Author(s):  
Fernando de BARROS ◽  
◽  
Sergio SETÚBAL ◽  
José Manoel MARTINHO ◽  
Loraine FERRAZ ◽  
...  
Keyword(s):  
Liver Disease ◽  
Fatty Liver ◽  
Fatty Liver Disease ◽  
Ldl Cholesterol ◽  
Glycated Hemoglobin ◽  
Morbidly Obese ◽  
Obese Patients ◽  
Alcoholic Fatty Liver ◽  
The Relationship ◽  
Alcoholic Fatty Liver Disease

ABSTRACT Background: Obesity is an epidemic and chronic disease that can bring other comorbidities to the patient. Non-alcoholic fatty liver disease is present in up to 90% of these patients and can progress to hepatitis and hepatocarcinoma. The relationship of this liver disease and obesity is already well known; however, it is possible that some parameters of the comorbidities are more related than others in the pathophysiology of the disease. Aim: Was analyzed the relationship between non-alcoholic fatty liver disease (NAFLD) and the comorbidities of metabolic syndrome in morbidly obese patients. Methods: Was involved ultrasonography and laboratory assessment of obese patients before bariatric surgery. NAFLD was assessed using the same sonography parameters for all patients. Based on the results, the patients were divided into groups with and without NAFLD. Comparisons between them involved clinical and laboratory variables such as fasting blood glucose, insulin, HOMA-IR (homeostasis model assessment - insulin resistance), glycated hemoglobin, total cholesterol and fractions, triglycerides, alanine aminotransferase, aspartate aminotransferase, gamma glutamyl transferase, C-reactive protein, albumin and ferritin. Patients who reported alcohol abuse (defined as the consumption of >14 drinks per week) or who had hepatitis were excluded. Results: Eighty-two patients (74 women and 8 men) were studied, of whom 53 (64.6%) had NAFLD and 29 (35.4%) did not. The levels of glycated hemoglobin (p=0.05) and LDL cholesterol (p=0.01) were significantly altered in patients with NAFLD. However, weight, body mass index and excess weight did not differ significantly between the groups (p=0.835, p=0.488 and p=0.727, respectively). Conclusions: Altered LDL cholesterol and glycated hemoglobin levels were related to the presence of NAFLD.

P1052 : An imbalance between Th17 and Treg key to pathogenesis of non-alcoholic fatty liver disease in morbidly obese patients

2015 ◽  
Vol 62 ◽  
pp. S743
Author(s):  
P. Iruzubieta ◽  
M.T. Arias-Loste ◽  
A. Domínguez ◽  
A. López-Useros ◽  
C. Santa Cruz ◽  
...  
Keyword(s):  
Liver Disease ◽  
Fatty Liver ◽  
Fatty Liver Disease ◽  
Morbidly Obese ◽  
Obese Patients ◽  
Alcoholic Fatty Liver ◽  
Alcoholic Fatty Liver Disease

Tu2019 Role of Vitamin D in the Inflammatory Response of Morbidly Obese Patients With Non-Alcoholic Fatty Liver Disease (NAFLD)

2014 ◽  
Vol 146 (5) ◽  
pp. S-900
Author(s):  
Katherine Doyle ◽  
Maria Keaton ◽  
Lei Wang ◽  
Rohini Mehta ◽  
Massih Abawi ◽  
...  
Keyword(s):  
Vitamin D ◽  
Liver Disease ◽  
Inflammatory Response ◽  
Fatty Liver ◽  
Fatty Liver Disease ◽  
Morbidly Obese ◽  
Obese Patients ◽  
Alcoholic Fatty Liver ◽  
Alcoholic Fatty Liver Disease

1245 ROLE OF INNATE AND ADAPTIVE IMMUNITY IN THE DEVELOPMENT OF NON ALCOHOLIC FATTY LIVER DISEASE IN MORBIDLY OBESE PATIENTS

2013 ◽  
Vol 58 ◽  
pp. S504-S505
Author(s):  
M.T. Arias Loste ◽  
P. Iruzubieta ◽  
R.A. Domínguez ◽  
M. Mallorga ◽  
M. López Hoyos ◽  
...  
Keyword(s):  
Liver Disease ◽  
Fatty Liver ◽  
Adaptive Immunity ◽  
Fatty Liver Disease ◽  
Morbidly Obese ◽  
Obese Patients ◽  
Alcoholic Fatty Liver ◽  
Innate And Adaptive Immunity ◽  
Alcoholic Fatty Liver Disease

Effects of sleeve gastrectomy on liver enzymes, non-alcoholic fatty liver disease-related fibrosis and steatosis scores in morbidly obese patients: first year follow-up

2019 ◽  
Vol 43 (2) ◽  
pp. 115-122
Author(s):  
Evrim Kahramanoğlu Aksoy ◽  
Zeynep Göktaş ◽  
Özgür Albuz ◽  
Muhammet Yener Akpınar ◽  
Doğan Öztürk ◽  
...  
Keyword(s):  
Sleeve Gastrectomy ◽  
Liver Disease ◽  
Fatty Liver ◽  
Fatty Liver Disease ◽  
Liver Enzymes ◽  
Morbidly Obese ◽  
Obese Patients ◽  
Alcoholic Fatty Liver ◽  
Alcoholic Fatty Liver Disease

Abstract Background Non-alcoholic fatty liver disease (NAFLD) has a high prevalence among patients undergoing laparoscopic sleeve gastrectomy (LSG). Although liver biopsy is the gold standard for assessing histopathologic changes in the liver, it is an invasive procedure. The objective of this study was to evaluate the effect of sleeve gastrectomy on liver enzymes, fibrosis and steatosis scores; ultrasonographic findings; biochemical parameters; and anthropometric measurements in morbidly obese patients with NAFLD. Methods Ninety-seven obese patients who underwent LSG were included in this study. Sex, age, body mass index (BMI), comorbidities, liver enzymes, ultrasonographic findings and laboratory parameters to calculate fibrosis and steatosis scores were collected before surgery and after 1 year of follow-up. Results A total of 88.7% of patients had liver steatosis at the pre-surgical ultrasonographic evaluation and this ratio decreased to 46.4% 1 year after surgery. Alanine aminotransferase (ALT), homeostatic model assessment of insulin resistance index (HOMA-IR), aspartate aminotransferase-to-platelet ratio index (APRI) and liver fat score (LFS) were significantly higher in patients with steatosis grade III vs. others. There were improvements in high-density lipoprotein (HDL), triglycerides (TG), glycated hemoglobin (HbA1c), glucose, insulin, BMI, liver enzymes and all NAFLD-related fibrosis and steatosis scores. Conclusions HOMA-IR, ALT, LFS and APRI scores can be used for follow-up procedures in morbidly obese patients with NAFLD who underwent LSG.

Sign in / Sign up

Export Citation Format

Share Document